MAM
APLT

Meeder Asset Management’s Applied Therapeutics APLT Stock Holding History

Meeder Asset Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-503
Closed -$10K – 1863
2020
Q3 		$10K Sell
503
-834
-62% -$21.7K ﹤0.01% 1363
2020
Q2 		$49K Buy
1,337
+1,330
+19,000% +$55.7K ﹤0.01% 921
2020
Q1 		$0 Buy
+7
New +$283 ﹤0.01% 2316

Other funds holding APLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Meeder Asset Management's APLT Position: Q4 2020 in Review

Meeder Asset Management sold out of Applied Therapeutics (APLT) in Q4 2020, closing a stake of 503 shares — an estimated $10K sold.

Meeder Asset Management first reported a position in APLT in Q1 2020 and held it in 3 quarters. The position peaked at $49K in Q2 2020. 67 funds tracked by Wall St. Rank hold APLT as of Q4 2020.

  • Meeder Asset Management reported no remaining Applied Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Meeder Asset Management sold 503 Applied Therapeutics shares in Q4 2020, an estimated $10K.
  • Meeder Asset Management first reported a position in Applied Therapeutics in Q1 2020 and held it in 3 quarters.
  • Meeder Asset Management's Applied Therapeutics position peaked at $49K in Q2 2020.
  • 67 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2020.

Based on Meeder Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.